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Peculiar Processing of Glucagon in the Intestines 
of Septic Stressed Patients 
K. Tanjoh*, R. Tomita, K. Kinoshita, A. Sakurai, 
S. Yoshida. Department o[ Emergency and Critical 
Care Medicine, Nihon University, Tokyo, Japan 
Background ~ Objectives: The kinetics of gtucagon 
in septic, stressed patients has not been investi- 
gated as thoroughly as that of insulin, despite its 
significant influence on energy metabolism. 
Method: In this study, the authors investigated the 
kinetics of gtucagon and gtucagon related peptides 
assessed by radioimmunoassay nd get filtration 
chromatography in 20 patients with acute abdom- 
inal disorders with sepsis underwent abdominal 
surgeries (group S), and discuss the gtucagon pro- 
cesses and the correlation of the gtucagon kinetics 
and energy metabolisms in these septic and surgi- 
caLLy stressed status. 10 normal subjects were also 
enroLLed as the control group (group C). 
Results: After surgeries, serum pancreatic gtucagon 
significantly increased compared to that of group C. 
In 19 of 20 patients in group S, the peculiar 
gLicentin-Like peptide (GLLP: MW around 8000) 
other than pancreatic gtucagon was estimated in 
gel filtration chromatography which was absoLuteLy 
not seen in group C and was presumed to had 
been generated from the gtucagon precursor in the 
intestine in a quite different gtucagon processes. 
Conclusions: In conclusion, the kinetics and the 
processing of gLucagon in most of patients with sep- 
sis was quite different from those of normal sub- 
jects. The peculiar mode of processing of gtucagons 
observed in the patients probably occurred in the 
intestine, generating peculiar gLicentin-Like pep- 
tides, which might reflect other changes in the 
endocrine system. 
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The Role of T-cell Subsets in Burns Patients 
Z. Entezami*, A. Khosravi, T. Mousavi, M.A. Bahar, 
P. Danesh. Iran University, Tehran, Iran 
Introduction: In aLL societies, burn continues to 
constitute a medicaL, psychologicaL, economic and 
social problem, in terms of morbidity and Long 
term disability, throughout the world. Changes in 
Lymphocyte count and injury of skin are important 
immunopathotogica[ symptoms after a burn acci- 
dent. Our aim is the study of peripheral blood Lym- 
phocyte subsets; CD3 (T ceLLs), CD4 (T helper), CD8 
(T cytotoxic) on different clays of burn patients. 
Methods: 67 male subjects aged between 18 and 60 
years with major burn injury were studied. WhoLe 
blood samples were coLLected (three and seven 
clays post burn accident). The samples were first 
stained with appropriate monocLona[ antibodies 
and then [yzed using DAKO [yzing solutions. Partec 
flow cytometry system and reagents, as recom- 
mended by manufacturers, DAKO (company prod- 
ucts), triple color was used. ALL results were ana- 
Lyzed by using the SPSS program. 
Results: The range and distribution of T ceLL sub- 
sets (CD3, CD4, CD8) of burned patients at seven 
and three days after the burn accident, were with 
mean percentages significant (P < 0.05). There was 
also a significant correlation between age groups 
and cause of burns (P < 0.05). ALL results were com- 
pared with controls. 
Conclusion: This study indicates that significant 
changes of Lymphocyte subset counts, in differ- 
ent age groups with percentage of burn, could be 
important rote in immunosuppressive and develop- 
merit of sepsis. CeLt and cytokine therapy should be 
a consideration i the evaluation of the immune 
status and may be a way to complete a more 
specific treatment in burn injuries. 
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Inflammatory Response during SIRS, Sepsis and 
Septic Shock: Prognostic Parameter in Patients 
of ICU 
M. Prucha*, R. Zazuta, I. Herotd, L. Dubska. 
Na Homolce Hospital, Dept. Clin. Biochemistry, 
Haematology and Immunology, 151 30 Prague 5, 
Czeck Republic 
Background E Objectives: Sepsis is a serious 
disease with a high mortality rate. A spectrum 
of changes in immune response appears in the 
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pathogenesis of sepsis, ranging from harmfut hy- 
perinflammation to profound immunodeficient im- 
munoparatysis. The fever of monocyte HLA-DR ex- 
pression and production of tumor necrosis factor- 
atpha ex vivo show the functionat status of mono- 
cytes as antigen presenting cetts. Infectious inflam- 
mation atso affects granutocyte CD64 expression. 
Other proinflammatory and antiinflammatory cy- 
tokines (tipopotysaccharide binding protein, IL-6, 
IL-10) are invotved in the pathogenesis of sepsis. 
The study aimed to determine importance and 
feasibitity of their evatuation in patients with SIRS, 
sepsis and septic shock. 
Materials & Methods: 67 patients meeting the 
criteria for diagnosis of systemic inflammatory re- 
sponse syndrome, sepsis and septic shock according 
to the Consensus conference, were examined. For 
determination of HLA-DR on monocytes and gran- 
utocyte CD64 expression flow cytometry was used. 
Resutts were expressed as MFI (mean fluorescence 
intensity) and QuantiBRITE (quantitation of anti- 
bodies bound per cett, kit fy Becton-Dickinson). 
Production of TNF-~ ex vivo after tipopotysac- 
charide stimutation was evatuated by Vottbtut- 
stimutation Kit (Mittenia). Determination of PCT, 
IL-6, IL-10 was evatuated by using chemituminis- 
cence method. 
Results: Expression of HLA-DR on monocytes and 
TNF-~ production corretated significantty with diag- 
nosis (Spearman's corretation coefficient r=-0.38, 
resp. -0.40, P <0.0001). We found significant dif- 
ferences of both parameters between subgroups 
of patients with SIRS and sepsis (P=0.0005), 
or SIRS and septic shock (P=0.006). The vat- 
ues of expression of HLA-DR corretated signif- 
icantty with vatues of TNF-~ in patients with 
SIRS and sepsis (P=0.0004, resp. P=0.0003). Last 
measured vatues of HLA-DR on monocytes and 
production of TNF-~ were significantty tower in 
non-survivors compared to survivors (P<0.001, 
resp. P<0.05). CD64 on granutocytes were sig- 
nificantty tower in patients with SIRS com- 
pared to patients with sepsis and septic shock 
(P < 0.0001, resp. P < 0.00001 ). The determination 
of CD64/45 and HLA-DR on monocytes using MFI 
corretated with QuantiBRITE method (rho=0.883, 
resp. 0.739, P < 0.00001, resp. P < 0.00001 ). Mono- 
cyte HLA-DR expression corretates with C-reactive 
protein (rho=-0.444, p=0.038). CD64 expres- 
sion on granutocytes corretates with medi- 
ators of systemic inflammation (procatcitonin 
PCT (rho=0.438, p=0.002), proinflammatory cy- 
tokines - interteukin-6 (rho=0.456, p=0.001), 
tipopotysaccharide binding protein (rho=0.446, 
p=0.002) and atso anti-inflammatory cytokines - 
IL-10 (rho=0.422, p=0.003). 
Conclusion: The assessment of the intensity of 
the inflammatory response hetps to predict the 
outcome of patients with sepsis and septic shock. 
Quantitative monocyte HLA-DR expression, produc- 
tion of TNF-~ ex vivo and CD64 expression on gran- 
utocytes are usefut parameters in septic patients, 
especiatty together with the pane[ of inflammatory 
cytokines in tong-term monitoring and in the con- 
text of the ctinicat status. 
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Intravenous Immmunoglobulins in the Treatment 
of Autoimmune Thrombocytopenia in Patients 
with Sepsis 
M. Prucha*, B. Kavka, M. Dosta[. Na Homolce 
Hospital, Dept.o[ Elin. Biochemistry, Haematology 
and Immunology, 151 30 Prague 5, Czech Republic 
Background: In the intensive care unit, thrombocy- 
topenia occurs in up to 20% of medica[ and 35% of 
surgica[ admissions. White there are many cause 
of thrombocytopenia in this setting, sepsis is a 
dear risk factor, with an estimated incidence of 
35-59%. In addition, there is an inverse retation- 
ship between the severity of sepsis and the ptate- 
[et count. Immune mechanisms may contribute 
to sepsis-induced thrombocytopenia. Nonspecific 
ptatetet-associated antibodies can be detected in 
up to 30% of ICU patients. Thrombocytopenia is 
a predictor of mortatity in ICU patients and in 
patients with severe sepsis. 
Objective: The aim of the study was to investigate 
immunotogica[ cause of thrombocytopenia in crit- 
icatty it[ patients and in the case of unsuccessfu[ 
standard therapy to use intravenous immunogtobu- 
tins. 
Subjects and Methods: 22 patients from ICU 
were investigated (8 women, 14 men) meeting the 
criteria of the Consensus conference about sep- 
sis. Art patients devetoped thrombocytopenia (tess 
than 50 G/L). 3 patients devetoped thrombocytope- 
nia tess than 5 G/L. These patients had petechie, 
bruising, and frank breeding. Ftow cytometry was 
used to detect ptatetet associated autoantibodies 
(fy Sitenius). 
Results: Of the 22 patients, positive ptatetet- 
associated immunogtobutins were detected in 7 pa- 
tients (32%). In 5 patients were ptatetet associated 
immunogtobutins positive in IgG and IgM isotype, 
in 2 patients in IgG, IgA, and IgM isotypes. 3 pa- 
tients had thrombocytopenia tess than 7G/L and 
did not answer to use of ptatetets concentrate, 
and were corticoresistant. For these patients we 
used the treatment with intravenous immunogtob- 
utins in immunosuppressive dose 400mg/kg/day. 
